Skip to main content
Supplement ScienceSupplementScience

Types of Vinpocetine: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Vinpocetine Tablets (5-10mg)Moderate (enhanced with food)Standard dosing — take with fatty food to increase absorption by up to 60%
Vinpocetine Extended ReleaseModerateSustained effect — maintains steady blood levels throughout the day

Vinpocetine Tablets (5-10mg)

Bioavailability: Moderate (enhanced with food). Best for: Standard dosing — take with fatty food to increase absorption by up to 60%.

Vinpocetine Extended Release

Bioavailability: Moderate. Best for: Sustained effect — maintains steady blood levels throughout the day.

References

  1. ReviewSzatmári S, Whitehouse P (2003). Vinpocetine for cognitive impairment and dementia. Cochrane Database of Systematic Reviews. DOI PubMed
  2. ReviewZhang YS, Li JD, Yan C (2018). An update on vinpocetine: new discoveries and clinical implications. European Journal of Pharmacology. DOI PubMed
  3. Meta-analysisPanda PK, Ramachandran A, Panda P, Sharawat IK (2022). Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.. Neurocritical care. DOI PubMed
  4. Meta-analysisBereczki D, Fekete I (2008). Vinpocetine for acute ischaemic stroke.. The Cochrane database of systematic reviews. DOI PubMed
  5. RCTBereczki D, Fekete I (2000). Vinpocetine for acute ischaemic stroke.. The Cochrane database of systematic reviews. DOI PubMed
  6. ReviewBereczki D, Fekete I (1999). A systematic review of vinpocetine therapy in acute ischaemic stroke.. European journal of clinical pharmacology. DOI PubMed
  7. ReviewBagoly E, Fehér G, Szapáry L (2007). [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].. Orvosi hetilap. DOI PubMed
Show 1 more reference
  1. Wang KN, Bell JS, Chen EYH, Gilmartin-Thomas JFM, et al. (2018). Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review.. Drugs & aging. DOI PubMed